Estimation of the correlation of insulin resistance and selected adipocytokines in children with simple obesity - Preliminary study;Ocena zwia̧zku insulinooporności z wybranymi adipocytokinami u dzieci z otyłościa̧ prosta̧ - Badania wstȩpne

Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego

Volumn 12, Issue 3, 2006, Pages 211-215

  Rudzka Kocjan, Agnieszka ^a,b   Szarras Czapnik, Maria ^a   Ksia̧zyk, Janusz B ^a   Ginalska Malinowska, Maria ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b Klinika Pediatrii   (Poland)

Author keywords

Adiponectin; Insulin resistance; Leptin; Resistin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; INSULIN; LEPTIN; RESISTIN; HORMONE; SIGNAL PEPTIDE;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; BODY MASS; CARBOHYDRATE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; ADIPOSE TISSUE; BLOOD; CHILD; FEMALE; MALE; PHYSIOLOGY; REGRESSION ANALYSIS; SECRETION; SENSITIVITY AND SPECIFICITY; STATISTICS;

ADIPONECTIN; ADIPOSE TISSUE; ADOLESCENT; BODY MASS INDEX; CHILD; FEMALE; HORMONES, ECTOPIC; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MALE; OBESITY; REGRESSION ANALYSIS; RESISTIN; SENSITIVITY AND SPECIFICITY; STATISTICS;

EID: 33749496682     PISSN: 1234625X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Odgen C.L., Flegal K.M., Carroll K.M., Johnson C.L.: Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA, 2002, 288, 1729.
2. Oblacińska A., Wojnarowska B.: Wystȩpowanie nadwagi i otyłości u dzieci i młodzieży szkolnej w Polsce - doniesienie wstȩpne. Nowa Med., 1995, 2, 24.
3. Goran M.I., Ball G.D.C., Cruz M.L: Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J. Clin. Endocrinol. Metab., 2003, 88, 1417-1427.
4. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 2001, 285, 2486-2497.
5. De Backer G., Ambrosioni E., Borch-Johnsen K.: Executive summary. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Prevention in Clinical Practice. Eur. Heart J., 2003, 24, 1601-1610.
6. Alberti G., Zimmet P., Shaw J. i wsp.: The IDF consensus worldwide definition of the metabolic syndrome, www.idf.org.
7. De Fronzo R.A., Ferrannini E.: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 1991, 14, 173.
8. Reaven G.M.: Insulin resistance and human disease: a short history. J. Basic Clin. Physiol. Pharmacol., 1998, 9, 387.
9. Pittas A.G., Joseph N.A., Greenberg A.S.: Adipocytokines and insulin resistance. J. Clin. Endocrinol. Metab., 2004, 89, 2447-2452.
10. Kershaw E.E., Flier J.S.: Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab., 2004, 89, 2548-2556.
11. Szalecki M., Pańkowska E., Ksia̧żyk J.B.: Adipocytokiny - hormony tkanki tłuszczowej - ich rola w homeostazie i patofizjologii. Klin. Pediatr, 2005, 13, 262-265.
12. Bjorbaek C., Kahn B.B.: Leptin signaling in the central nervous system and the periphery. Horm. Res., 2004, 59, 305-331.
13. Chandran P., Philips S.A., Ciaraldi T., Henry R.R.: Adiponectin: more than just another fat cell hormone? Diabetes Care, 2003, 26, 2442-2450.
14. Assayama K., Hayashibe H., Dobashi K. i wsp.: Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes. Res., 2003, 11, 1072-1079.
15. Degawa-Yamauchi M., Bovenkerk J.E., Juliar B.E. i wsp.: Serum resistin (FIZZ3) is increased in obese humans. J. Clin. Endocrinol. Metab., 2003, 88, 5452-5455.
16. Lee J.H., Chan J.L., Yiannakouris N. i wsp.: Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J. Clin. Endocrinol. Metab., 2003, 88, 4848-4856.
17. Palczewska I., Szilagyi-Pa̧gowska I.: Ocena rozwoju somatycznego dzieci i młodzieży. Medycyna Praktyczna - Pediatria, 2002, 3, 140.
18. Boyd G.S., Koenigsberg J., Falkner B. i wsp.: Effect of obesity and high blood pressure on plasma lipid levels in children and adolescents. Pediatrics, 2005, 116, 442-446.
19. Cruz LM, Goran M.I.: Zespół metaboliczny u dzieci i młodzieży. Medycyna po Dyplomie, 2004, 13, 85-101.
20. Hu G., Qiao Q., Tuomilehto J. i wsp.: Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular moratlity in nondiabetic European men and women. Arch. Intern. Med., 2004, 164, 1066-1076.
21. Cook S., Weitzman M., Auinger P. i wsp.: Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third national Health and Nutrition Examination Survey, 1988-1994. Arch. Pediatr. Adolesc. Med., 2003, 157, 821-827.
22. Ten S., Maclaren N.: Insulin resistance syndrome in children. J. Clin. Endocrinol. Metab., 2004, 89, 2526-2539.
23. American Diabetes Association: Type 2 diabetes in children and adolescents. Pediatrics, 2000, 105, 671-680.
24. Young-Hyman D., Schlundt D., Herman L. i wsp.: Evaluation of the insulin resistance syndrome in 5-to-10-year old overweight/obese African-American children. Diabetes Care, 2001, 24, 1359-1364.